scholarly journals Cost-consequence analysis evaluating multifaceted clinical pharmacist intervention targeting patient transitions of care from hospital to primary care

2018 ◽  
Vol 2 (2) ◽  
pp. 123-130 ◽  
Author(s):  
Maja Kjaer Rasmussen ◽  
Lene Vestergaard Ravn-Nielsen ◽  
Marie-Louise Duckert ◽  
Mia Lolk Lund ◽  
Jolene Pilegaard Henriksen ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Transitions Of Care ◽  
Consequence Analysis ◽  
Cost Consequence ◽  
Clinical Pharmacist Intervention

scholarly journals PCV122 THE IMPACT OF A CLINICAL PHARMACIST INTERVENTION ON LIPID-LOWERING IN A PRIMARY CARE SETTING

2010 ◽  
Vol 13 (7) ◽  
pp. A364
Author(s):  
N Triki ◽  
S Shani ◽  
D Rabinovich-Protter ◽  
D Mossinson ◽  
E Kokia ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Care Setting ◽  
Primary Care Setting ◽  
Pharmacist Intervention ◽  
Lipid Lowering ◽  
The Impact ◽  
Clinical Pharmacist Intervention

scholarly journals Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial

BMJ Open ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. e036650
Author(s):  
Jonas Kindstedt ◽  
Sofia Svahn ◽  
Maria Sjölander ◽  
Eva-Lotta Glader ◽  
Hugo Lövheim ◽  
...  
Keyword(s):  
Clinical Pharmacist ◽  
Hospital Admissions ◽  
Controlled Trial ◽  
Hospital Readmissions ◽  
The Elderly ◽  
Pharmacist Intervention ◽  
Transitions Of Care ◽  
Ethical Review ◽  
Randomised Controlled ◽  
Clinical Pharmacist Intervention

IntroductionDrug-related problems (DRPs) are a major cause of unplanned hospital admissions among elderly people, and transitions of care have been emphasised as a key area for improving patient safety. We have designed a complex clinical pharmacist intervention that targets people ≥75 years of age undergoing transitions of care from hospital to home and primary care. The main objective is to investigate if the intervention can reduce the risk of unplanned drug-related readmission within the first 180 days after the person is discharged from hospital.Methods and analysisThis is a randomised, controlled, superiority trial with two parallel arms. A total of 700 people ≥75 years will be assigned to either intervention or routine care (control). The intervention, which aims to find and manage DRPs, is initiated within a week of the person being discharged from hospital and combines repeated medical chart reviews, phone interviews and in some cases medication reviews. People in both study arms may have been the subject of a medication review during their ward stay. As the primary outcome, we will measure time until unplanned drug-related readmission within 180 days of leaving hospital and use log rank tests and Cox proportional hazard models to analyse differences between the groups. Further investigations of subgroup effects and adjustments of the regression models will be based on heart failure and cognitive impairment as prognostic factors.Ethics and disseminationThe study has been approved by the Regional Ethical Review Board in Umeå (registration numbers 2017-69-31M, 2018-83-32M and 2018-254-32M). We intend to publish the results with open access in international peer-reviewed journals and present our findings at international conferences. The trial is expected to result in more than one published article and form part of two PhD theses.Trial registration numberNCT03671629

Description of a clinical pharmacist intervention administered to primary care patients with depression

2004 ◽  
Vol 26 (3) ◽  
pp. 210-218 ◽  
Author(s):  
Kathleen M Bungay ◽  
David A Adler ◽  
William H Rogers ◽  
Christopher McCoy ◽  
Maryann Kaszuba ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Primary Care Patients ◽  
Clinical Pharmacist Intervention

Pharmacist Review to Simplify Medication Regimens in a VAMC Primary Care Clinic

1996 ◽  
Vol 12 (2) ◽  
pp. 62-66 ◽  
Author(s):  
Paul V Laucka ◽  
Will B Webster ◽  
Jeffrey Kuch
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Primary Care Clinic ◽  
Intervention Group ◽  
Pharmacist Intervention ◽  
Control Group ◽  
Care Clinic ◽  
Before And After ◽  
Clinical Pharmacist Intervention ◽  
Clinic Visits

Objective: To assess the effect of a clinical pharmacist's prospective medication review of patients receiving multiple drug therapy, using the pharmaceutical care process, as determined by the number of concurrent medications the patient is receiving before and after clinic visits. Design: Assigned groups. Setting: Outpatient primary care clinic of a tertiary healthcare Veterans Affairs (VA) medical facility. Patients: Seven hundred twenty-seven patients who had eight or more active medication orders were selected. Four hundred forty-one patients (aged 67.2 ± 10.4 y) were in the intervention group; 286 others (aged 66.6 ± 11.9 y), whose medical records were not available, were assigned to the control group and received no clinical pharmacist intervention. Intervention: Medication regimens of VA ambulatory patients with eight or more active medications were reviewed by a clinical pharmacist, and a written communication to the prescriber was attached to the medical record. Main Outcome Measures: The number of active concurrent medications before and after clinic visits was measured. Results: There was a decrease in the medications in the intervention group from an average of 12.1 ±4 to 11.5 ± 4.2 (p < 0.05). The medications in the control group rose from an average of 11.8 ± 4.44 to 12.2 ± 4 (p = NS). A decrease of 0.6 prescriptions per patient was highly significant (p < 0.05). During the study, 1,336 recommendations were made to practitioners. From this group, 41% of the recommendations were accepted, and 477 medications were discontinued, the quantity dispensed or dosage was reduced, or an alternative medication was prescribed. Conclusions: These data suggest that clinical pharmacist intervention in an ambulatory care setting can affect practitioner prescribing habits and significantly decrease the number of medications prescribed.

scholarly journals Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia

2018 ◽  
Vol 18 (1) ◽  
pp. 81 ◽  
Author(s):  
Vina A. Sagita ◽  
Anton Bahtiar ◽  
Retnosari Andrajati
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
General Hospital ◽  
Clinical Pharmacist ◽  
Drug Effects ◽  
Pharmacist Intervention ◽  
Drug Related Problems ◽  
Clinical Problems ◽  
Clinical Pharmacist Intervention

Objectives: This study aimed to evaluate the role of a clinical pharmacist intervention in decreasing subsequent clinical and drug-related problems (DRPs) among coronary heart disease (CHD) inpatients with at least one previous DRP. Methods: This pre-experimental study with a pre-post design was carried out from January to April 2017 among inpatients with at least one previous DRP at a general hospital in Tangerang District, Banten, Indonesia. Clinical and DRPs were documented prospectively by a clinical pharmacist, with DRPs classified using Version 6.2 of the DRP classification scheme of the Pharmaceutical Care Network Europe Foundation. The intervention consisted of a discussion of identified DRPs with physicians, patients, pharmaceutical logistics clerks, nurses and nutritionists. Following this, any subsequent clinical and DRPs were re-identified and further interventions were conducted as necessary. Results: A total of 75 inpatients were included in the study. Pre-intervention, there were 443 DRPs and 202 clinical problems. The most frequent DRPs were adverse drug reactions (52.6%), followed by drug effects (41.8%). Most DRPs were of moderate severity and would have resulted in moderate consequences had the pharmacist not intervened. The interventions resulted in a significant reduction in the number of DRPs, type of DRPs and number of clinical problems (P <0.05 each). Patients with complications were 26.047 times more likely to have no reduction or an increased number of clinical problems compared to patients without complications (P <0.05). Conclusion: Clinical pharmacist interventions were found to reduce subsequent DRPs and clinical problems among CHD patients with at least one previous DRP.

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam

2018 ◽  
Vol 33 (12) ◽  
pp. 711-722 ◽  
Author(s):  
Hilary J. Navy ◽  
Linda Weffald ◽  
Thomas Delate ◽  
Rachana J. Patel ◽  
Jennifer P. Dugan
Keyword(s):  
Older Adults ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Clinical Pharmacist Intervention
Sign in / Sign up

Export Citation Format

Share Document